SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Columbia Care Inc. – ‘8-K’ for 9/20/22

On:  Thursday, 9/22/22, at 9:01pm ET   ·   As of:  9/23/22   ·   For:  9/20/22   ·   Accession #:  1193125-22-249416   ·   File #:  0-56294

Previous ‘8-K’:  ‘8-K’ on 8/16/22 for 8/15/22   ·   Next:  ‘8-K’ on 11/15/22 for 11/14/22   ·   Latest:  ‘8-K’ on 3/20/24 for 3/14/24

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 9/23/22  Columbia Care Inc.                8-K:5       9/20/22   10:138K                                   Donnelley … Solutions/FA

Current Report   —   Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     31K 
 5: R1          Document and Entity Information                     HTML     44K 
 8: XML         IDEA XML File -- Filing Summary                      XML     11K 
 6: XML         XBRL Instance -- d397508d8k_htm                      XML     13K 
 7: EXCEL       IDEA Workbook of Financial Reports                  XLSX      8K 
 3: EX-101.LAB  XBRL Labels -- ck0001776738-20220920_lab             XML     51K 
 4: EX-101.PRE  XBRL Presentations -- ck0001776738-20220920_pre      XML     32K 
 2: EX-101.SCH  XBRL Schema -- ck0001776738-20220920                 XSD     11K 
 9: JSON        XBRL Instance as JSON Data -- MetaLinks               11±    17K 
10: ZIP         XBRL Zipped Folder -- 0001193125-22-249416-xbrl      Zip     12K 


‘8-K’   —   Current Report


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 iX: 
  8-K  
 i false  i 0001776738 0001776738 2022-09-20 2022-09-20

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM  i 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported):  i September 20, 2022

 

 

 i COLUMBIA CARE INC.

(Exact Name of Registrant as specified in its charter)

 

 

 

 i British Columbia    i 000-56294    i 98-1488978

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

 i 680 Fifth Ave.,  i 24th Floor

 i New York,  i New York

   i 10019
(Address of principal executive offices)   (Zip Code)

( i 212)  i 634-7100

(Registrant’s telephone number, including area code)

Not Applicable

(Registrant’s name or former address, if change since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

 i 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 i 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 i 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 i 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act: None.

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging Growth Company  i 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 13(a) of the Exchange Act.  i 

 

 

 


Item 5.07

Submission of Matters to a Vote of Security Holders.

At the annual general meeting of shareholders of Columbia Care Inc., (the “Company”) held virtually at 11:00 a.m. (Toronto time) on September 20, 2022 (the “Meeting”), the Company’s shareholders voted on the following proposals, which are described in detail in the Company’s definitive proxy statement and information circular filed with the United States Securities and Exchange Commission on August 29, 2022 (the “Circular”): (i) to elect nine (9) directors to serve on the Company’s board of directors until the next annual meeting of shareholders or until their successors are duly elected or appointed (“Proposal 1”), and (ii) to re-appoint Davidson & Company LLP as the auditor of the Company to hold office until the next annual meeting of shareholders and to authorize the directors of the Company to fix the auditor’s remuneration (“Proposal 2”).

Set forth below are the final voting results with respect to each of the proposals acted upon at the Meeting, including the number of votes cast for and against (or withheld), and the number of abstentions and broker non-votes with respect to each such proposal.

Proposal 1: Election of Directors

At the Meeting, each of the following nine (9) nominees were elected to serve on the Company’s board of directors until the next annual meeting of shareholders or until their successors are duly elected or appointed, by a vote held by ballot in respect of each nominee as follows:

 

Directors    FOR    WITHHELD    BROKER NON-VOTES

Nicholas Vita

   115,340,138    4,632,880    25,722,069

Michael Abbott

   112,854,970    7,118,048    25,722,069

Frank Savage

   114,522,688    5,450,330    25,722,069

James A.C. Kennedy

   118,891,321    1,081,697    25,722,069

Jonathan P. May

   119,079,350    893,668    25,722,069

Jeff Clarke

   119,069,317    903,701    25,722,069

Alison Worthington

   119,308,625    664,393    25,722,069

Julie Hill

   119,335,770    637,248    25,722,069

Philip Goldberg

   116,870,341    3,102,677    25,722,069

Proposal 2: Re-appointment of Auditor

At the Meeting, the shareholders voted to re-appoint Davidson & Company LLP as the auditor of the Company to hold office until the next annual meeting of shareholders and to authorize the directors of the Company to fix the auditor’s remuneration, by a vote held by ballot as follows:

 

FOR   AGAINST   ABSTAIN

145,490,237

  125,102   79,748


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

COLUMBIA CARE INC.
By:  

/s/ Nicholas Vita

Name:   Nicholas Vita
Title:   Chief Executive Officer

Date: September 22, 2022


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘8-K’ Filing    Date    Other Filings
Filed as of:9/23/22
Filed on:9/22/22
For Period end:9/20/22DEF 14A
8/29/22DEF 14A
 List all Filings 
Top
Filing Submission 0001193125-22-249416   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., Mar. 29, 11:40:46.1am ET